MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-02-0032454
Pentaproud Pharmaceuticals Private Limited
Pentaproud Pharmaceuticals Private Limited - pharma in Kochi, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹37.93 Lakh
▼ 23% YoY
Net loss · FY 2025
₹7.7 Lakh
Net margin -20.3%
EBITDA · FY 2025
-₹6.79 Lakh
EBITDA margin -17.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Pentaproud Pharmaceuticals Private Limited
Data last updated:
Pentaproud Pharmaceuticals Private Limited is a private limited company based in Kochi, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51909KL2016PTC045990. Its GSTIN is 32AAICP6350P1Z0 (Kerala).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Binoy Jacob Vattamthattayil and Thazhathe Purakkal Sujith.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No.13/640 – A2 Pipeline Road Thrikkakara, Kochi, Kerala, India – 682021.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.93 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net loss of ₹7.7 Lakh (net margin -20.3%) and EBITDA of -₹6.79 Lakh (EBITDA margin -17.9%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 12% over five years.
Pentaproud Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0032454). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909KL2016PTC045990
Registration Number 045990
Incorporation Date 10 June 2016
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-02-0032454
Key People
Binoy Jacob Vattamthattayil Director Thazhathe Purakkal Sujith Director Jamsheed Chennengadan Director Recognitions & Rankings of Pentaproud Pharmaceuticals
Contact details
Pentaproud Pharmaceuticals Private Limited's registered office is in Kochi, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDoor No.13/640 – A2 Pipeline Road Thrikkakara, Kochi, Kerala, India – 682021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pentaproud Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Pentaproud Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pentaproud Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pentaproud Pharmaceuticals Private Limited, buy the company report.
Financials of Pentaproud Pharmaceuticals Private Limited
FY 2025 filings availablePentaproud Pharmaceuticals Private Limited reported revenue of ₹37.93 Lakh (down 23% YoY) for FY 2025.
Revenue · FY 2025
₹37.93 Lakh ▼ 23%
Net loss · FY 2025
₹7.7 Lakh margin -20.3%
EBITDA · FY 2025
-₹6.79 Lakh margin -17.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 12%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▲ 55%
3 years · compounded
▼ 49%
5 years · compounded
▼ 49%
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 23% fall in the latest year. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17.9% | ||||
| Net Profit Margin | -20.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pentaproud Pharmaceuticals Private Limited, buy the company report.
Board of directors of Pentaproud Pharmaceuticals Private Limited
Pentaproud Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Binoy Jacob Vattamthattayil | Director | 10 Jun 2016 | 10 Years 4 Months | Current |
| Thazhathe Purakkal Sujith | Director | 10 Jun 2016 | 10 Years 4 Months | Current |
| Jamsheed Chennengadan | Director | 07 Oct 2017 | 9 Years 0 Months | Current |
| Dheepu Varghese | Director | 10 Jun 2016 | 10 Years 4 Months | Current |
Peer comparison
Pentaproud Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Katharine Pharmaceuticals Private Limited | ₹38.1 Lakh (FY 2025) | 45.0% | Jaipur, Rajasthan, India | |||
| Eton Biotech Private Limited | ₹38.09 Lakh (FY 2022) | Ambala, Haryana, India | ||||
| Pentaproud Pharmaceuticals Private Limitedthis company | ₹37.93 Lakh (FY 2025) | -₹7.7 Lakh | -20.3% | -23.0% | Kochi, Kerala, India | |
| Futurewell Pharmaceuticals Private Limited | ₹37.89 Lakh (FY 2024) | Kolkata, West Bengal, India | ||||
| Himcure Pharmaceuticals Private Limited | ₹37.86 Lakh (FY 2024) | 22.0% | Rampur, Uttar Pradesh, India |
To see the full peer comparison of Pentaproud Pharmaceuticals Private Limited, buy the company report.
Auditor
Pentaproud Pharmaceuticals Private Limited is audited by J K V & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J K V & CO | FY 2021 | 015411S |
Shareholding
The shareholding of Pentaproud Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pentaproud Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pentaproud Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pentaproud Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pentaproud Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAICP6350P1Z0 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pentaproud Pharmaceuticals Private Limited, buy the company report.
Recent activity
Pentaproud Pharmaceuticals Private Limited has 5 board changes on record since 2016: 4 appointments and 1 cessation. The latest: Jamsheed Chennengadan ceased to be Additional Director on 27 Sep 2018.
AGM
Pentaproud Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Pentaproud Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Ceased
Jamsheed Chennengadan ceased to be Additional Director.
Appointed
Jamsheed Chennengadan was appointed as Director.
Appointed
Binoy Jacob Vattamthattayil was appointed as Director.
Appointed
Dheepu Varghese was appointed as Director.
Appointed
Thazhathe Purakkal Sujith was appointed as Director.
Incorporation
10 Jun 2016
Pentaproud Pharmaceuticals Private Limited was registered on 10 Jun 2016 with Roc Ernakulam & aged 10 years 4 months as per MCA records.
Frequently asked questions
Pentaproud Pharmaceuticals is an active private limited company based in Kochi, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 June 2016 (10+ years old) and is registered under CIN U51909KL2016PTC045990.
Pentaproud Pharmaceuticals has 4 current directors:
- Binoy Jacob Vattamthattayil - Director
- Thazhathe Purakkal Sujith - Director
- Jamsheed Chennengadan - Director
- Dheepu Varghese - Director
The latest financial statements of Pentaproud Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Pentaproud Pharmaceuticals is 32AAICP6350P1Z0, registered in Kerala.
The CIN (Corporate Identification Number) of Pentaproud Pharmaceuticals is U51909KL2016PTC045990. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pentaproud Pharmaceuticals was incorporated on 10 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Pentaproud Pharmaceuticals by revenue are Katharine Pharmaceuticals Private Limited, Eton Biotech Private Limited, Futurewell Pharmaceuticals Private Limited, Himcure Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Jamsheed Chennengadan ceased to be Additional Director on 27 Sep 2018. Jamsheed Chennengadan was appointed as Director on 07 Oct 2017. Binoy Jacob Vattamthattayil was appointed as Director on 10 Jun 2016. Pentaproud Pharmaceuticals has 5 board changes on record in total.
Yes, Pentaproud Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-02-0032454).
The registered office of Pentaproud Pharmaceuticals is at Door No.13640 – A2 Pipeline Road Thrikkakara, Kochi, Kerala, India – 682021.
Pentaproud Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.